Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

RCAS1 is associated with ductal breast cancer progression.

Authors: Rousseau, J  Tetu, B  Caron, D  Malenfant, P  Cattaruzzi, P  Audette, M  Doillon, C  Tremblay, JP  Guerette, B 
Citation: Rousseau J, etal., Biochem Biophys Res Commun. 2002 May 24;293(5):1544-9.
Pubmed: (View Article at PubMed) PMID:12054692
DOI: Full-text: DOI:10.1016/S0006-291X(02)00401-1

RCAS1/EBAG9 (receptor-binding cancer antigen expressed on SiSo cells/ estrogen receptor-binding fragment-associated gene 9), an estrogen-transcribed protein, has been shown to be expressed in a wide variety of cancers, including uterine, ovarian, and lung cancer cells. Soluble and membranous RCAS1 proteins may play a role in the immune escape of tumor cells by promoting T lymphocyte inhibition of growth and apoptosis. In the present report, the presence of RCAS1 was revealed in human ductal breast cancer biopsies by immunohistochemistry. Its cytoplasmic expression was exhibited in cancer cells obtained from tumor biopsies and in breast cancer cell lines. RCAS1 significantly correlated with tumor grade. In addition, RCAS1 was identified in MCF7 culture supernatants. Those observations suggest that RCAS1 is a new marker for breast cancer progression and a possible mechanism for breast cancer immune escape.


Disease Annotations
Objects Annotated

Additional Information

RGD Object Information
RGD ID: 2298489
Created: 2008-07-01
Species: All species
Last Modified: 2008-07-01
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.